Search | VHL Search Portal

1.

Emerging strategies: PARP inhibitors in combination with immune checkpoint blockade in BRCA1 and BRCA2 mutation-associated and triple-negative breast cancer.

Gupta, Tanya; Vinayak, Shaveta; Telli, Melinda.

Breast Cancer Res Treat ; 197(1): 51-56, 2023 Jan.

Article in English | MEDLINE | ID: mdl-36318381

2.

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.

Lenz, Lauren; Neff, Chris; Solimeno, Cara; Cogan, Elizabeth S; Abramson, Vandana G; Boughey, Judy C; Falkson, Carla; Goetz, Matthew P; Ford, James M; Gradishar, William J; Jankowitz, Rachel C; Kaklamani, Virginia G; Marcom, P Kelly; Richardson, Andrea L; Storniolo, Anna Maria; Tung, Nadine M; Vinayak, Shaveta; Hodgson, Darren R; Lai, Zhongwu; Dearden, Simon; Hennessy, Bryan T; Mayer, Erica L; Mills, Gordon B; Slavin, Thomas P; Gutin, Alexander; Connolly, Roisin M; Telli, Melinda L; Stearns, Vered; Lanchbury, Jerry S; Timms, Kirsten M.

Breast Cancer Res Treat ; 202(1): 191-201, 2023 Nov.

Article in English | MEDLINE | ID: mdl-37589839

3.

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.

Doherty, Mary R; Cheon, HyeonJoo; Junk, Damian J; Vinayak, Shaveta; Varadan, Vinay; Telli, Melinda L; Ford, James M; Stark, George R; Jackson, Mark W.

Proc Natl Acad Sci U S A ; 114(52): 13792-13797, 2017 12 26.

Article in English | MEDLINE | ID: mdl-29229854

4.

Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?

Vinayak, Shaveta; Davidson, Nancy E.

Oncology (Williston Park) ; 33(6): 243-6, 2019 06 19.

Article in English | MEDLINE | ID: mdl-31219612

5.

Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.

Telli, Melinda L; Hellyer, Jessica; Audeh, William; Jensen, Kristin C; Bose, Shikha; Timms, Kirsten M; Gutin, Alexander; Abkevich, Victor; Peterson, Rebecca N; Neff, Chris; Hughes, Elisha; Sangale, Zaina; Jones, Joshua; Hartman, Anne-Renee; Chang, Pei-Jen; Vinayak, Shaveta; Wenstrup, Richard; Ford, James M.

Breast Cancer Res Treat ; 168(3): 625-630, 2018 Apr.

Article in English | MEDLINE | ID: mdl-29275435

6.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Daly, Mary B; Pilarski, Robert; Berry, Michael; Buys, Saundra S; Farmer, Meagan; Friedman, Susan; Garber, Judy E; Kauff, Noah D; Khan, Seema; Klein, Catherine; Kohlmann, Wendy; Kurian, Allison; Litton, Jennifer K; Madlensky, Lisa; Merajver, Sofia D; Offit, Kenneth; Pal, Tuya; Reiser, Gwen; Shannon, Kristen Mahoney; Swisher, Elizabeth; Vinayak, Shaveta; Voian, Nicoleta C; Weitzel, Jeffrey N; Wick, Myra J; Wiesner, Georgia L; Dwyer, Mary; Darlow, Susan.

J Natl Compr Canc Netw ; 15(1): 9-20, 2017 01.

Article in English | MEDLINE | ID: mdl-28040716

7.

Role of Platinum in Early-Stage Triple-Negative Breast Cancer.

La Belle, Alyssa; Khatib, Jude; Schiemann, William P; Vinayak, Shaveta.

Curr Treat Options Oncol ; 18(11): 68, 2017 11 06.

Article in English | MEDLINE | ID: mdl-29110096

8.

Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline.

Shaitelman, Simona F; Anderson, Bethany M; Arthur, Douglas W; Bazan, Jose G; Bellon, Jennifer R; Bradfield, Lisa; Coles, Charlotte E; Gerber, Naamit K; Kathpal, Madeera; Kim, Leonard; Laronga, Christine; Meattini, Icro; Nichols, Elizabeth M; Pierce, Lori J; Poppe, Matthew M; Spears, Patricia A; Vinayak, Shaveta; Whelan, Timothy; Lyons, Janice A.

Pract Radiat Oncol ; 14(2): 112-132, 2024.

Article in English | MEDLINE | ID: mdl-37977261

9.

A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.

Vinayak, Shaveta; Schwartz, Erich J; Jensen, Kristin; Lipson, Jafi; Alli, Elizabeth; McPherson, Lisa; Fernandez, Adrian M; Sharma, Vandana B; Staton, Ashley; Mills, Meredith A; Schackmann, Elizabeth A; Telli, Melinda L; Kardashian, Ani; Ford, James M; Kurian, Allison W.

Breast Cancer Res Treat ; 142(2): 389-98, 2013 Nov.

Article in English | MEDLINE | ID: mdl-24166281

10.

mTOR inhibitors in the treatment of breast cancer.

Vinayak, Shaveta; Carlson, Robert W.

Oncology (Williston Park) ; 27(1): 38-44, 46, 48 passim, 2013 Jan.

Article in English | MEDLINE | ID: mdl-23461041

11.

A breast multi-disciplinary genomic tumor board is feasible and can provide timely and impactful recommendations.

Tsung, Karen; Thompson, Cheryl L; Knight, Joy M; Maximuk, Steve; Sadri, Navid; Gilmore, Hannah; Keri, Ruth A; Vinayak, Shaveta; Harris, Lyndsay; Silverman, Paula.

Breast J ; 24(4): 676-677, 2018 07.

Article in English | MEDLINE | ID: mdl-29517142

12.

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.

Nagaraj, Gayathri; Vinayak, Shaveta; Khaki, Ali Raza; Sun, Tianyi; Kuderer, Nicole M; Aboulafia, David M; Acoba, Jared D; Awosika, Joy; Bakouny, Ziad; Balmaceda, Nicole B; Bao, Ting; Bashir, Babar; Berg, Stephanie; Bilen, Mehmet A; Bindal, Poorva; Blau, Sibel; Bodin, Brianne E; Borno, Hala T; Castellano, Cecilia; Choi, Horyun; Deeken, John; Desai, Aakash; Edwin, Natasha; Feldman, Lawrence E; Flora, Daniel B; Friese, Christopher R; Galsky, Matthew D; Gonzalez, Cyndi J; Grivas, Petros; Gupta, Shilpa; Haynam, Marcy; Heilman, Hannah; Hershman, Dawn L; Hwang, Clara; Jani, Chinmay; Jhawar, Sachin R; Joshi, Monika; Kaklamani, Virginia; Klein, Elizabeth J; Knox, Natalie; Koshkin, Vadim S; Kulkarni, Amit A; Kwon, Daniel H; Labaki, Chris; Lammers, Philip E; Lathrop, Kate I; Lewis, Mark A; Li, Xuanyi; de Lima Lopes, Gilberto; Lyman, Gary H.

medRxiv ; 2023 Mar 10.

Article in English | MEDLINE | ID: mdl-37205429

13.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.

Nagaraj, Gayathri; Vinayak, Shaveta; Khaki, Ali Raza; Sun, Tianyi; Kuderer, Nicole M; Aboulafia, David M; Acoba, Jared D; Awosika, Joy; Bakouny, Ziad; Balmaceda, Nicole B; Bao, Ting; Bashir, Babar; Berg, Stephanie; Bilen, Mehmet A; Bindal, Poorva; Blau, Sibel; Bodin, Brianne E; Borno, Hala T; Castellano, Cecilia; Choi, Horyun; Deeken, John; Desai, Aakash; Edwin, Natasha; Feldman, Lawrence E; Flora, Daniel B; Friese, Christopher R; Galsky, Matthew D; Gonzalez, Cyndi J; Grivas, Petros; Gupta, Shilpa; Haynam, Marcy; Heilman, Hannah; Hershman, Dawn L; Hwang, Clara; Jani, Chinmay; Jhawar, Sachin R; Joshi, Monika; Kaklamani, Virginia; Klein, Elizabeth J; Knox, Natalie; Koshkin, Vadim S; Kulkarni, Amit A; Kwon, Daniel H; Labaki, Chris; Lammers, Philip E; Lathrop, Kate I; Lewis, Mark A; Li, Xuanyi; Lopes, Gilbert de Lima; Lyman, Gary H.

Elife ; 122023 10 17.

Article in English | MEDLINE | ID: mdl-37846664

14.

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.

Moy, Beverly; Rumble, R Bryan; Come, Steven E; Davidson, Nancy E; Di Leo, Angelo; Gralow, Julie R; Hortobagyi, Gabriel N; Yee, Douglas; Smith, Ian E; Chavez-MacGregor, Mariana; Nanda, Rita; McArthur, Heather L; Spring, Laura; Reeder-Hayes, Katherine E; Ruddy, Kathryn J; Unger, Paul S; Vinayak, Shaveta; Irvin, William J; Armaghani, Avan; Danso, Michael A; Dickson, Natalie; Turner, Sophie S; Perkins, Cheryl L; Carey, Lisa A.

J Clin Oncol ; 39(35): 3938-3958, 2021 12 10.

Article in English | MEDLINE | ID: mdl-34324366

15.

5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers.

Zhao, Yiqing; Feng, Xiujing; Chen, Yicheng; Selfridge, J Eva; Gorityala, Shashank; Du, Zhanwen; Wang, Janet M; Hao, Yujun; Cioffi, Gino; Conlon, Ronald A; Barnholtz-Sloan, Jill S; Saltzman, Joel; Krishnamurthi, Smitha S; Vinayak, Shaveta; Veigl, Martina; Xu, Yan; Bajor, David L; Markowitz, Sanford D; Meropol, Neal J; Eads, Jennifer R; Wang, Zhenghe.

Cancer Res ; 80(21): 4815-4827, 2020 11 01.

Article in English | MEDLINE | ID: mdl-32907836

16.

Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis.

Telli, Melinda L; Chu, Charles; Badve, Sunil S; Vinayak, Shaveta; Silver, Daniel P; Isakoff, Steven J; Kaklamani, Virginia; Gradishar, William; Stearns, Vered; Connolly, Roisin M; Ford, James M; Gruber, Joshua J; Adams, Sylvia; Garber, Judy; Tung, Nadine; Neff, Chris; Bernhisel, Ryan; Timms, Kirsten M; Richardson, Andrea L.

Clin Cancer Res ; 26(11): 2704-2710, 2020 06 01.

Article in English | MEDLINE | ID: mdl-31796517

17.

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.

Tung, Nadine M; Robson, Mark E; Ventz, Steffen; Santa-Maria, Cesar A; Nanda, Rita; Marcom, Paul K; Shah, Payal D; Ballinger, Tarah J; Yang, Eddy S; Vinayak, Shaveta; Melisko, Michelle; Brufsky, Adam; DeMeo, Michelle; Jenkins, Colby; Domchek, Susan; D'Andrea, Alan; Lin, Nancy U; Hughes, Melissa E; Carey, Lisa A; Wagle, Nick; Wulf, Gerburg M; Krop, Ian E; Wolff, Antonio C; Winer, Eric P; Garber, Judy E.

J Clin Oncol ; 38(36): 4274-4282, 2020 12 20.

Article in English | MEDLINE | ID: mdl-33119476

18.

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.

Vinayak, Shaveta; Tolaney, Sara M; Schwartzberg, Lee; Mita, Monica; McCann, Georgia; Tan, Antoinette R; Wahner-Hendrickson, Andrea E; Forero, Andres; Anders, Carey; Wulf, Gerburg M; Dillon, Patrick; Lynce, Filipa; Zarwan, Corrine; Erban, John K; Zhou, Yinghui; Buerstatte, Nathan; Graham, Julie R; Arora, Sujata; Dezube, Bruce J; Telli, Melinda L.

JAMA Oncol ; 5(8): 1132-1140, 2019 Aug 01.

Article in English | MEDLINE | ID: mdl-31194225

19.

Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline

Shaitelman, Simona F; Anderson, Bethany M; Arthur, Douglas W; Bazan, Jose G; Bellon, Jennifer R; Bradfield, Lisa; Coles, Charlotte E; Gerber, Naamit K; Kathpal, Madeera; Kim, Leonard; Laronga, Christine; Meattini, Icro; Nichols, Elizabeth M; Pierce, Lori J; Poppe, Matthew M; Spears, Patricia A; Vinayak, Shaveta; Whelan, Timothy; Lyons, Janice A.

Practical radiation oncology (Online) ; 12: 112-132, 20240101.

Article in English | BIGG | ID: biblio-1537630

20.

Publisher's Note to Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline (Pract Radiat Oncol. 2024;14:xxx-xxx. Epub ahead of print November 14, 2023.).

Shaitelman, Simona F; Anderson, Bethany M; Arthur, Douglas W; Bazan, Jose G; Bellon, Jennifer R; Bradfield, Lisa; Coles, Charlotte E; Gerber, Naamit K; Kathpal, Madeera; Kim, Leonard; Laronga, Christine; Meattini, Icro; Nichols, Elizabeth M; Pierce, Lori J; Poppe, Matthew M; Spears, Patricia A; Vinayak, Shaveta; Whelan, Timothy; Lyons, Janice A.

Pract Radiat Oncol ; 2023 Nov 18.

Article in English | MEDLINE | ID: mdl-37984712

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

Emerging strategies: PARP inhibitors in combination with immune checkpoint blockade in BRCA1 and BRCA2 mutation-associated and triple-negative breast cancer.

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.

Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?

Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Role of Platinum in Early-Stage Triple-Negative Breast Cancer.

Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline.

A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.

mTOR inhibitors in the treatment of breast cancer.

A breast multi-disciplinary genomic tumor board is feasible and can provide timely and impactful recommendations.

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.

5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers.

Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis.

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.

Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline

Publisher's Note to Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline (Pract Radiat Oncol. 2024;14:xxx-xxx. Epub ahead of print November 14, 2023.).